Results 181 to 190 of about 798,481 (288)
Schematic illustration of ROS‐responsive TSPBA‐PVA microspheres loaded with 20‐deoxyingenol (TP/20‐DOI) for diabetic corneal wound healing: (a) fabrication and ROS‐triggered release; (b) autophagy activation and metabolic reprogramming in macrophages; (c) suppression of macrophage‐derived CXCL3/CXCL5, attenuation of neutrophil infiltration, and ...
Jiaxin Wu +20 more
wiley +1 more source
Treating tuberous sclerosis-associated cardiac rhabdomyomas with mTOR inhibitors in preterm. [PDF]
Pasquinucci M +3 more
europepmc +1 more source
mTOR Inhibitors Modulate the Physical Properties of 3D Spheroids Derived from H9c2 Cells. [PDF]
Watanabe M +6 more
europepmc +1 more source
Photobiomodulated microglia release engineered extracellular vesicles that deliver UFL1 to the injured spinal cord. UFL1 competitively binds p53 with MDM2, inhibiting p53 ubiquitination and stabilizing p53 signaling. This dual mechanism simultaneously promotes anti‐inflammatory microglial polarization and directs neural stem cell differentiation toward
Yunxiao Fang +12 more
wiley +1 more source
Effect of mTOR inhibitors on sodium taurocholate cotransporting polypeptide (NTCP) function in vitro. [PDF]
Saran C +3 more
europepmc +1 more source
This bioinspired acinus‐on‐a‐chip recapitulates VILI pathology, revealing that volutrauma drives P53/NF‐κB pathways while barotrauma triggers mitochondrial‐Wnt dysregulation. A fibrotic transitional cell cluster was identified. Pharmacological interventions targeting these pathways significantly ameliorated injury, establishing a mechanobiological ...
Heng Lu +10 more
wiley +1 more source
A review of PI3K/AKT/mTOR inhibitors from traditional Chinese medicine: potential and perspective for activated phosphoinositide 3-kinase δ syndrome. [PDF]
Xie Y, Nie L, Bai L, Zhao X.
europepmc +1 more source
Recent advances and limitations of mTOR inhibitors in the treatment of cancer. [PDF]
Ali ES +9 more
europepmc +1 more source
Selective Modulation of OTUB1 Noncanonical Function via a bioPhosTAC Strategy
This work positions the versatile performance of the peptide‐based bioPhosTAC platform for dissecting phosphorylation‐dependent biology and expanding the scope of induced‐proximity technologies. We demonstrated that selective manipulation of a tyrosine phosphorylation site is sufficient to propagate coordinated cellular consequences.
Seung Un Seo +7 more
wiley +1 more source
<i>In Silico</i> Identification of Chiral Biflavonoids as Dual PI3Kα/mTOR Inhibitors. [PDF]
Nunes Azevedo FF +5 more
europepmc +1 more source

